A randomized trial in cancer-related fatigue in palliatively treated patients: protocolized patient-tailored treatment of physical symptoms (PPT) vs care as usual (CAU).
Completed
- Conditions
- 1. Advanced cancer<br />2. fatigue<br />3. cancer-related fatigue<br />4. CRF<br />5. palliative care.<br />(NLD: kanker, vermoeidheid, kankergerelateerde vermoeidheid, palliatieve zorg).
- Registration Number
- NL-OMON23161
- Lead Sponsor
- Erasmus MC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 152
Inclusion Criteria
1. Histologically or cytologically proven solid malignancy;
2. Palliatively aimed treatment;
Exclusion Criteria
1. Concomitant (or within 4 weeks before randomization) administration of any
experimental drug;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method General fatigue at baseline and 1, 2 and 3 months after baseline. Measured with the MFI.
- Secondary Outcome Measures
Name Time Method 1. Quality of life (EORTC QLQ C30);<br /><br>2. Multidimensional fatigue (MFI);<br /><br>3. Daily interference of fatigue (BFI);<br /><br>4. Anxiety and depression (HADS);<br /><br>5. Survival.